Concept information
Preferred term
CME-Carbodiimide
Type
-
mesh:Descriptor
Broader concept
Entry terms
- 2491-17-0
- 4-(2-((Cyclohexylimidocarbonyl)amino)ethyl)-4-methylmorpholinium
- CMEC
- CME Carbodiimide
- Morpholinium, 4-(2-((cyclohexylcarbonimidoyl)amino)ethyl)-4-methyl-, salt with 4-methylbenzenesulfonic acid (1:1)
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
In other languages
-
French
-
2491-17-0
-
Carbodiimide CME
-
Morpholinium, 4-(2-((cyclohexylcarbonimidoyl)amino)ethyl)-4-methyl-, salt with 4-methylbenzenesulfonic acid (1:1)
-
p-Toluènesulfonate de 4-(2-((cyclohexylimino)méthylène)amino)éthyl-4-méthylmorpholinium
-
para-Toluènesulfonate de 4-(2-((cyclohexylimino)méthylène)amino)éthyl-4-méthylmorpholinium
-
Tosylate de 4-(2-((cyclohexylimino)méthylène)amino)éthyl-4-méthylmorpholinium
URI
http://data.loterre.fr/ark:/67375/JVR-C0GPR7DB-8
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}